Clinical Trial Update: Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing albumin-bound sirolimus in combination with endocrine therapy for HR+/HER2- advanced/metastatic breast cancer after failure of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• Sirolimus (Albumin-Bound) (sirolimus)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: HR+/HER2- Advanced/Metastatic Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING